{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T16:36:16Z","timestamp":1777307776190,"version":"3.51.4"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Dublin, Trinity College"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10875-025-01881-3","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T04:21:28Z","timestamp":1745209288000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A Novel Description of Immunodeficiency and Immune Dysregulation in a 14-Year-Old Girl with Noonan Syndrome 13"],"prefix":"10.1007","volume":"45","author":[{"given":"Saira","family":"Tabassum","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Gr\u00fcn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben","family":"Molloy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eppie","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick G.","family":"Buckley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Amet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony M.","family":"McElligott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek G.","family":"Doherty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Ehl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6419-9328","authenticated-orcid":false,"given":"Timothy Ronan","family":"Leahy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,21]]},"reference":[{"issue":"3","key":"1881_CR1","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.ajhg.2020.06.018","volume":"107","author":"M Motta","year":"2020","unstructured":"Motta M, et al. Enhanced MAPK1 function causes a neurodevelopmental disorder within the rasopathy clinical spectrum. Am J Hum Genet. 2020;107(3):499\u2013513.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"1881_CR2","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/ajmg.c.32012","volume":"190","author":"M Tartaglia","year":"2022","unstructured":"Tartaglia M, Aoki Y, Gelb BD. The molecular genetics of rasopathies: an update on novel disease genes and new disorders. Am J Med Genet C Semin Med Genet. 2022;190(4):425\u201339.","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"2","key":"1881_CR3","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.semarthrit.2013.04.009","volume":"43","author":"B Bader-Meunier","year":"2013","unstructured":"Bader-Meunier B, et al. Are rasopathies new Monogenic predisposing conditions to the development of systemic lupus erythematosus? Case report and systematic review of the literature. Semin Arthritis Rheum. 2013;43(2):217\u20139.","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"1881_CR4","first-page":"242","volume":"46","author":"J Bernier-Buzzanga","year":"1990","unstructured":"Bernier-Buzzanga J, Su WP. Noonan\u2019s syndrome with extensive verrucae. Cutis. 1990;46(3):242\u20136.","journal-title":"Cutis"},{"issue":"6160","key":"1881_CR5","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1126\/science.1243292","volume":"342","author":"I Angulo","year":"2013","unstructured":"Angulo I, et al. Phosphoinositide 3-kinase \u0394 gene mutation predisposes to respiratory infection and airway damage. Science. 2013;342(6160):866\u201371.","journal-title":"Science"},{"issue":"1","key":"1881_CR6","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/ni.2771","volume":"15","author":"CL Lucas","year":"2014","unstructured":"Lucas CL, et al. Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110\u03b4 result in T cell senescence and human immunodeficiency. Nat Immunol. 2014;15(1):88\u201397.","journal-title":"Nat Immunol"},{"issue":"13","key":"1881_CR7","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1084\/jem.20141759","volume":"211","author":"CL Lucas","year":"2014","unstructured":"Lucas CL, et al. Heterozygous splice mutation in PIK3R1 causes human immunodeficiency with lymphoproliferation due to dominant activation of PI3K. J Exp Med. 2014;211(13):2537\u201347.","journal-title":"J Exp Med"},{"key":"1881_CR8","doi-asserted-by":"publisher","first-page":"966","DOI":"10.3389\/fimmu.2018.00966","volume":"9","author":"S Jung","year":"2018","unstructured":"Jung S, et al. Immune TOR-opathies, a novel disease entity in clinical immunology. Front Immunol. 2018;9:966.","journal-title":"Front Immunol"},{"key":"1881_CR9","doi-asserted-by":"publisher","first-page":"568","DOI":"10.3389\/fimmu.2018.00568","volume":"9","author":"T Asano","year":"2018","unstructured":"Asano T, et al. Enhanced AKT phosphorylation of Circulating B cells in patients with activated PI3K\u03b4 syndrome. Front Immunol. 2018;9:568.","journal-title":"Front Immunol"},{"issue":"6","key":"1881_CR10","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.tibs.2011.03.006","volume":"36","author":"MC Mendoza","year":"2011","unstructured":"Mendoza MC, Er EE, Blenis J. The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation. Trends Biochem Sci. 2011;36(6):320\u20138.","journal-title":"Trends Biochem Sci"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-025-01881-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-025-01881-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-025-01881-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T15:45:22Z","timestamp":1777304722000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-025-01881-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,21]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1881"],"URL":"https:\/\/doi.org\/10.1007\/s10875-025-01881-3","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,21]]},"assertion":[{"value":"15 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Case report approved by Research Ethics Committee, CHI at Crumlin, Dublin. Whole Genome Sequencing approved as part of \u201cRare Diseases Study\u201d, approved by Research Ethics Committee, CHI at Temple St. Dublin. Research was conducted in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Informed consent was obtained for publication of this case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}},{"value":"Written informed consent was obtained from the study participant\u2019s parents to participate in the research.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Authors BM, EJ, and PGB were employed by the company Genuity Science. The remaining authors declare that the research was conducted without any commercial or financial relationships that could be construed as a potential conflict ofinterest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"87"}}